Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2017 09:01 ET | Source: Prevacus, Inc.

Prevacus Inc., Announces the Addition of Randy Travis to its Advisory Board

TALLAHASSEE, Fla., June 26, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
February 22, 2017 10:15 ET | Source: Prevacus, Inc.

Prevacus Announces the Addition of Key Individuals to its Sports Advisory Board

TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
February 15, 2017 08:00 ET | Source: Prevacus, Inc.

Prevacus Announces Appearance on Fox Business

TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
February 09, 2017 16:01 ET | Source: Prevacus, Inc.

Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion

TALLAHASSEE, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion aka mild Traumatic Brain Injury (mTBI) and...